Newsletters
ePaper
Sign in
Home
India
Assembly Polls 2024
Karnataka
Opinion
World
Business
Sports
Entertainment
Video
News Shots
Explainers
Bengaluru
Science
Trending
Photos
DH Brandspot
DH Specials
Home
News Shots
Trending
Menu
×
ADVERTISEMENT
ADVERTISEMENT
Remedisvir injections
Remdesivir stocks: A reality check
The anti-viral drug is scarce. Pharma companies expect supplies to improve in less than a week
17 August 2021, 08:16 IST
Remdesivir stocks: A reality check
17 August 2021, 08:16 IST
Covid-19: MP govt to give free 3-month ration to poor
Chouhan said there would be no shortage of money in tackling the pandemic
19 April 2021, 19:13 IST
Covid-19: MP govt to give free 3-month ration to poor
19 April 2021, 19:13 IST
Jubilant Pharma finishes study using oral formulation
Jubilant has sought authorisation for additional studies for this novel oral formulation from the Drug Controller General of India
19 April 2021, 11:28 IST
Jubilant Pharma finishes study using oral formulation
19 April 2021, 11:28 IST
From The Newsroom: Delhi announces weekend curfew
15 April 2021, 15:03 IST
From The Newsroom: Delhi announces weekend curfew
15 April 2021, 15:03 IST
Centre gives nod to ramping up Remdesivir production
The current total installed capacity of the seven manufacturers of Remdesivir is 38.80 lakh vials per month
14 April 2021, 16:31 IST
Centre gives nod to ramping up Remdesivir production
14 April 2021, 16:31 IST
UP to procure 25,000 Remdesivir injections from Gujarat
Remdesivir is considered a key antiviral drug in fight against Covid-19
14 April 2021, 09:09 IST
UP to procure 25,000 Remdesivir injections from Gujarat
14 April 2021, 09:09 IST
Zydus Cadila reduces price of Covid-19 drug
This move to further revise the prices will go a long way in helping patients during these critical times
24 March 2021, 11:59 IST
Zydus Cadila reduces price of Covid-19 drug
24 March 2021, 11:59 IST
Vaccines alone are not enough to beat Covid-19
While these drugs can be helpful, their requirement for intravenous administration severely hampers their widespread use
07 February 2021, 18:15 IST
Vaccines alone are not enough to beat Covid-19
07 February 2021, 18:15 IST
Russian firm seeks to produce Covid drug without patent
Pharmasyntez previously approached Gilead requesting a voluntary licence to produce and distribute the drug in Russia
02 November 2020, 09:26 IST
Russian firm seeks to produce Covid drug without patent
02 November 2020, 09:26 IST
Gilead Inc raises sales outlook to include remdesivir
31 July 2020, 07:14 IST
Gilead Inc raises sales outlook to include remdesivir
31 July 2020, 07:14 IST
<
1
2
>